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Hydrogen-bonded interpolymer complexes (IPCs) formed
between poly(carboxylic acids) and differentwater-soluble
non-ionic cellulose ethers such as methylcellulose (MC),
hydroxypropylcellulose, hydroxypropylmethylcellulose,
and hydroxyethylcellulose are of growing interest because
ofvariousapplicationsof thesepolymers inpharmaceutical
and biomedical areas.[1–3] Poly(acrylic acid) (PAA) and its
weakly cross-linkedderivatives (Carbopols) arewidelyused
as mucoadhesives in various pharmaceutical formulations
due to their excellent adhesion to biological surfaces.[4–6]
The presence of a mucoadhesive polymer in a formulation
often helps to retain a dosage form on the site of
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226administration and improves drug bioavailability. Excel-
lent mucoadhesive properties of poly(acrylic acid) are
related to its ability to bind to mucins through hydrogen-
bonding.[7] However, the applicability of PAA and its
derivatives in drug delivery via transmucosal routes
is limited because these polymers are often too hydro-
philic (resulting in quick dissolution or excessive swell-
ing), have relatively poor film forming and mechanical
characteristics, and sometimes cause irritation to sensi-
tive mucosal surfaces.[8] Non-ionic cellulose ethers
have numerous pharmaceutical applications ranging
from liquid ophthalmic and nasal formulations to
emulsifiers and excipients used for manufacturing
tablets.[9,10] They are typically less mucoadhesive than
polycarboxylate polymers but have excellent biocompat-
ibility profiles and film forming properties.[11] A combi-
nation of PAA with cellulose ethers is expected to
provide materials with improved physicochemical and
biological characteristics.
Previously, we have studied the complexation between
PAA and MC in aqueous solutions by turbidimetric
titration, isothermal titration calorimetry, transmission
electron microscopy, and surface plasmon resonance
(Biacore) and evaluated the effects of pH and solution
concentration on the intensity of interactions and struc-
ture of IPCs formed.[12–16] Rheological properties of PAA–
MC complexes in aqueous solutions were also reported
by other authors.[17] It was established that the
complexes formed have non-stoichiometric nature and
contain excessive molar quantities of PAA. Formation
of insoluble complexes was observed at pHs below
the critical pH of complexation (pHcrit), which values
dependedonpolymer concentrations. Polymer solutions of
0.01 unit-base mol1 exhibited the pHcrit of 3.10 0.05,
whereas at 0.05 unit-base mol the pHcrit was observed at
3.30 0.05.[13] Multilayered ultrathin hydrogel films
and coatings have been developed from PAA–MC using
layer-by-layer deposition of IPC on the surface of un-
modified[14,15] and chemically modified microscopy glass
slides,[16] respectively.
In this study,wehave further investigated complexation
between PAA and MC in aqueous solutions with an
emphasis on the structure and aggregation stability of
IPC nanoparticles as a function of PAA–MC ratios in the
mixture and solution pH using dynamic light scattering.
Wehavealso establishedoptimal conditions for developing
uniform films by casting PAA–MC solution mixtures and
demonstrated the importance of balancing the strength
of hydrogen bonding between the polymers to avoid
intensive complexation/aggregation at low pHs and
complete immiscibility at relatively high pHs. Optimized
conditions for casting homogeneous PAA/MC blends were
used to develop mucoadhesive films for ocular delivery of
riboflavin.Macromol. Biosci. 20
 2013 The Authors. Published by WILEY-VCH2. Experimental Section
2.1. Materials
PAA (Mn 450 kDa)was supplied by Sigma–Aldrich (UK). Methylcel-
lulose (Methocel 60 HG; 93 kDa) with 28–30% methoxyl content
was purchased from Fluka (UK). The viscosity of 2wt% methylcel-
lulose (MC) in water at 20 8C was 35–55 mPa  s. Both polymers
were used without further purification. All other chemicals such
as hydrochloric acid, sodium hydroxide, riboflavin, and buffer
solutions were purchased from Sigma–Aldrich (UK) and used
without further purification.2.2. Preparation of Solutions and Adjustment of pH
Polymer solutions were prepared by dissolving the required
amounts of MC or PAA in deionized water at defined pH and
leaving it stirring overnight at room temperature. The pH of the
solutions was then further adjusted by adding small amounts of
0.1M HCl or NaOH and was measured using a digital pH-meter
(Metrohm, Switzerland).2.3. Dynamic Light Scattering
The size of IPC particles formed in aqueous solutions at various
polymer ratios and solution pHs was studied by dynamic light
scattering (DLS) at 25 8CusingaMalvernZetasizerNano-S (Malvern
Instruments, UK). Each DLS experiment was repeated in triplicate
by preparing and analyzing solutions of each polymer sample
separately.2.4. Turbidimetric Measurements
Turbidity of aqueous mixtures of PAA and MC was examined at
400nm with a V-530PC spectrophotometer (Jasco, UK). In these
experiments, samples were prepared by mixing PAA and MC
solutions of different concentrations (0.2, 1.0, and 2.0wt%) and pH
(1, 2, 3, and 4) and were left stirring overnight before turbidity
readings were taken.2.5. Preparation of Films
Homogeneous drug-loaded films were prepared using 3wt% PAA
and MC solutions in ultrapure water (18.2 V). 200mL of each
solutionwasstirredovernightand16mgriboflavinadded,shielded
with aluminium foil and again stirred overnight. The solutionwas
adjusted to pH 4.5 using HCl (0.1M) or NaOH (0.1 M), stirred for a
further 2h and pH adjusted as necessary. Solutions were mixed
in differentproportions. Similar protocolwasused to prepare drug-
free films without addition of riboflavin. These solutions were
used to cast films by pouring 50mL into 100mm100mm Petri
dishes, which were subsequently placed in a ventilated chamber,
shielded from light for 5 d. Each film appeared uniform in
thickness and color, they were relatively easy to detach from
the Petri dishes. Care was taken to minimize exposure to light
during handling due to the photosensitivity of riboflavin.14, 14, 225–234
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SEM experiments used an FEI Quanta FEG 600 Environmental
Scanning Electron Microscope with an acceleration voltage of
20 kV. The surface of PAA–MCfilmswas sputteredwith gold before
analysis.2.7. Slug Mucosal Irritation Test
The slug mucosal irritation test (SMIT) was carried out with the
drug-free films as described in our previous publication.[18] Limax
flavus and Arion lusitanicus slugs weighing 3–8 g were sourced
locally (Reading, UK). Individual slugs were kept in 2.5 L glass
beakers lined with a paper towel moistened with 20mL PBS
solution and left at room temperature for 2 d before the start of an
experiment. In both positive and negative controlsWhatman filter
paper moistened with 2mL 1% benzalkonium chloride in PBS
and 2mL PBS solution, respectively, were used to line 90mm Petri
dishes.Thesamplesoffilmsweremoistenedwith2mLPBSsolution
just before the experiments with slugs were carried out.
Each slug was individually weighed before the experiment and
then placed in Petri dishes containing either polymeric sample, or
positive/negative controls. After 1 h contact period slugs were
taken out, rinsedwith 10mL PBS, gentlywipedwith a tissue paper
and re-weighed. The mucus production (MP) was estimated as a
slug body weight loss and calculated by the following formula:www.MMP ¼ ðmb maÞmb  100% ð1Þwhere mb and ma are the weights of a slug before and after
experiment, respectively. Each experimentwas repeated4–6 times
using different slugs and the results were statistically treated,
calculating the mean values standard deviations.2.8. In Vitro Drug Release Studies
10mmdiscs containing40mg riboflavinwere cut fromfilms tobe
used for release studies. The thickness of these films measured
using digital micrometer was around 0.15mm. It was noticed that
filmswith a high PAA contentwere substantiallymore brittle than
those of lower PAA content. The average weight of the films was
1.5 g and the average weight of each disc was 15mg. Riboflavin-
loaded discs were placed in 50mL plastic vials and positioned in a
water bath with a shaker stage. The temperature was set to 34 8C
and the stage set to reciprocate at 100 times per minute. 5mL of
simulated tear fluid was added and 100mL samples were taken at
10min intervals for 1h. Each aliquot was placed in a 1.8mL auto
sample vial and 900mL of ultrapure water added to dilute it for
analysis. Analysiswas carried out usingHPLC (Perkin Elmer)with a
C18 reversed phase column. Each experiment was carried out in
triplicate.2.9. In Vivo Experiments
In vivo experiments on ocular administration of riboflavin films
were conducted on chinchilla rabbits (2.5–3.0 kg). These experi-Macromol. Biosci. 20
 2013 The Authors. Published by WILEY-VaterialsViews.comments were approved by Semey State Medical University ethics
committee andwere conducted following the ARVO Statement for
the Use of Animals in Ophthalmic and Visual Research. Prior to
experiments, rabbits were housed in standard cages and allowed
free access to food and water. During the experiments rabbits
were placed in restraining boxes, where their eye and eye-lid
movements were not restricted. Polymeric discs containing
riboflavin (10mm in diameter) were quickly soaked (10 s) in a
saline solution (0.9% NaCl) and carefully placed on rabbit left
eye’s cornea; their right eye always served as a control. The
behavior of each polymeric disc on the eyewasmonitored visually
and images were taken at regular time intervals with a high
resolutiondigital camera.Eachtypeofpolymericfilmwastestedon
three rabbits and each experiment was conducted for 60min.2.10. Statistical Analysis
The results on slug mucosal irritation and drug release data were
analysed by using one-way analysis of variance (ANOVA) using
Minitab 16 software (version 16.1.1).3. Results and Discussion
3.1. Structure and Colloidal Stability of Interpolymer
Complexes
All our previous studies of complexation between PAA and
MC in aqueous solutions were focused on determination
of the stoichiometry of complexation,[12,13] probing the
complexation strength and thermodynamics,[14] evalua-
tion of pH and concentration effects on the formation,
structural organization, and stability of IPCs,[12–14] and the
fabrication of PAA–MCbasedmultilayeredmaterials.[14–16]
We have established the possibility of forming PAA–MC
complexes as nanoparticles when 0.2wt% polymer sol-
utions were mixed at 30:70wt% ratio at pHs 1.4, 2.4, and
3.2,[14] however, did not evaluate the stability of these
colloidal suspensions to aggregation. In this study, we
applied dynamic light scattering (DLS) to look at the effects
of polymer ratio and pH on the size, size distribution and
colloidal stability of IPC nanoparticles. Figure 1a presents
DLS data on the complexes formed by PAA and MC at
different polymer ratios at pH3.0. It canbe clearly seen that
IPCs formed by mixing polymers at 50:50wt% ratio have
the smallest size of approximately 100–120nm and these
nanoparticles have a relatively narrow size distribution
(Figure 1b). This polymer ratio is consistent with the IPC
stoichiometry established earlier.[14] When the composi-
tion of a polymermixture deviates from the stoichiometric
ratio the size of particles increases. For example, the size
of nanoparticles formed by mixing 10wt% of PAA with
90wt% MC is nearly doubled in comparison with the
dimensions of IPCs formed at 50:50wt% polymers ratio.
It can be expected that this increase is associated with14, 14, 225–234
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Figure 1. a) Size of IPCs formed by mixing 0.2wt% solutions
PAA and MC at different ratios at pH 3.0. b) Size distribution
of PAA–MC (50:50wt%) complexes.
Figure 2. a) Effect of pH and time on the particle size for
interpolymer complexes formed by mixing 0.2% solutions of
PAA and MC (30:70wt%). b) Physical appearance of IPC
solutions at different pHs.
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228formation of larger and looser structures incorporating
fragments of uncomplexed macromolecules present in
the mixture in excess.
The growth in nanoparticles size is more pronounced in
the presence of excessive quantities of MC, which is
possibly related to its non-ionic nature having poorer
ability to stabilize colloidal structures against aggregation.
It should be noted that the colloidal stability of IPC
nanoparticles improves when the polymers are mixed at
ratios deviating from the stoichiometic one (50:50wt%),
therefore in further work on the complexation we have
used 30:70wt% PAA–MC ratios.
In our earlier study,[14] we applied transmission electron
microscopy (TEM) and observed an interesting structural
transformation of IPC nanoparticles when solution pH
was changed from 1.4 to 3.2. IPCs formed at pH 1.4 and
2.4 had spherical and dense structure with a particle
size ranging from 80 to 200nm, whereas nanoparticles
formed at pH 3.2 were much smaller (20–30nm) and
were apparently stabilized by a network of uncomplexed
macromolecules. DLS study of pH effect on the size of
IPCs performed in the current work confirms the presence
of this interesting structural reorganization (Figure 2a),
however, there is a discrepancy in the nanoparticle sizesMacromol. Biosci. 20
 2013 The Authors. Published by WILEY-VCHdetermined by TEM and DLS. In the present study nano-
particles formed at pHs 3.2–3.6 have the smallest dimen-
sions of approximately 160nm. It possibly corresponds to a
situationwhennanoparticles are stabilizedbyanetwork of
uncomplexed loops and tails, therefore they are less prone
to aggregation andmaintain small sizes and good colloidal
stability. A further decrease in pH down to 2.5 results in
a dramatic increase in particle size up to 340nm, which
is likely to be due to the involvement of uncomplexed
macromolecular loops and tails in the complexation
leading to a loss of surface hydrophilicity/steric stabiliza-
tion and subsequent aggregation. Reduction in solution pH
below 2.5 does not result in major changes in particle size.
When pH is above 3.6 the size of nanoparticles increases
again; this may be associated with a gradual disruption
of hydrogen bonding leading to formation of looser and
more swollen structures. However, unfortunately, the14, 14, 225–234
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changes with the complexes at higher pH was limited
possibly due to less dense structures of the associates and
their inability to scatter laser light efficiently.
Data on the effect of pH on the IPC particle sizes are
consistentwith visual observations (Figure 2b). At pHs 3.39
and 3.5 the IPC solutions show only minor cloudiness,
whereas at lower pHs (3.28, 3.07, 2.85, and 2.72) they form
notably cloudy systems.
The discrepancy between particle sizes determined by
DLS in the present study and TEM data from our previously
published work[14] is likely related to differences in sample
hydration. Indeed, the sizes of IPCs determined by DLS
are significantly larger as the nanoparticles are being
measured in solutions in their fully hydrated and swollen
form. When nanoparticles were studied by TEM their
sizes tend to be much smaller because of the sample
preparation technique involving drying (de-hydration and
contraction of nanoparticles).
To get a further insight into the colloidal stability of
IPCs formed at different pHs we continued our DLS
experiments by leaving samples undisturbed at room
temperature and periodicallymeasuring their particle size.
As it is seen from the results shown in Figure 2 IPCs
show a tendency to increase their particle size with time,
i.e. they gradually undergo aggregation. At pHs 3.2–3.6
aggregation is not very pronounced and nanoparticles
increase their size from 160 to 190nm within 10 d. This
is possibly explained by steric stabilization of IPC by
uncomplexed loops and tails. At lower pHs aggregation is
more notable with its peak observed at pH 2.4–2.5: particle
size increases from 340nm on day 0 to 570nm on day 10.
Upon further decrease in pH from 2.5 to 1.0 the nano-
particles gradually become more stable to aggregation
again. These observations are consistent with data
reported by Usaitis et al.,[19] who studied the aggregation
kinetics of complexes formed by poly(methacrylic acid)
and polyvinylpyrrolidone. They also established that
fastest and most intensive particle size growth is observed
at pH 3.2, whereas a slower aggregation is taking place at
pHs 3.4 and 3.6.
It is important to note that an intensive growth in
the IPCs particle size observed at pH below 3.2–3.3
agrees well with our previously reported turbidimetric
determination of pHcrit.
[12,13]
The understanding of the complex formation between
PAA and MC in aqueous solutions at different pHs is of
significant interest for practical applications, especially for
the development of novel dosage forms. Nanoparticles
formed by PAA–MC complexes can be used to formulate
drug delivery systems, e.g., as nano-containers for poorly
soluble drugs because of presence of hydrophobic domains
in the IPC structure. In this case, their colloidal stability in
aqueous systems is very important. On the other hand theMacromol. Biosci. 20
 2013 The Authors. Published by WILEY-VCwww.MaterialsViews.comformation, structure and stability of IPC nanoparticlesmay
affect the possibility for preparation of solid dosage forms
for drug delivery. In the next sections, the importance of
controlling the complexation by selecting the optimal pH
conditions will be demonstrated for the preparation of
polymeric films based on PAA–MC blends.3.2. Optimization of Films Casting Conditions and
Assessment of their Physical Properties
Formation of IPC between PAA and MC accompanied by
their aggregation and precipitation can be considered as a
limitation for preparing homogeneous polymeric films by
casting from solutionmixtures. Indeed, the films, prepared
from solutions with strong aggregation and precipitation
of complexes, are not uniform, not fully transparent and
have poor mechanical properties. In order to optimize
the properties of films we have studied the extent of
complexation between the polymers as a function of
solution pH and polymer concentrations using simple
turbidimetric measurements (Figure 3). The mixtures of
PAA and MC at pH< 4.0 display high values of solution
turbidity indicating their poor suitability for casting films.
At pH 4.0 and above the solution mixtures show good
transparency and no signs of phase separation.
To examine the effect of solution pH on the properties of
polymericfilmswehaveprepareda seriesof samples cast at
various pHs (2.5, 3.0, 3.4, 4.0, 4.4, and 8.3) and probed their
surface morphology by scanning electron microscopy
(Figure 4). The scanning electron microscopy (SEM) images
of samples cast at pHs 2.5 and 3.0 indicate high degree of
sample irregularity likely related to the formation of IPC
aggregates as pH conditions for these samples favor
intensive complex formation between the polymers.
Indeed, the presence of IPC nanoparticles incorporated in
the structure of the film can clearly be seen in the sample
prepared at pH 3.0. Films prepared at pHs 3.4, 4.0, and 4.4
show completely uniform morphology and miscibility
between PAA and MC, whereas the sample cast at 8.3
displays the presence of a phase separation. The irregular
morphology of the latter sample is related to immiscibility
between MC and PAA, whose carboxylic groups are fully
ionized. The immiscible nature of this blend is likely to be
due to the lack of intermacromolecular hydrogen bonding
ensuring compatibility between the polymers.[20] Similar
pH-induced complexation, miscibility, immiscibility tran-
sitions in the polymeric blends have been previously
reported by us for PAA and poly(vinyl alcohol),[21]
polyethylene oxide[22] and hydroxypropylcellulose.[23]3.3. Mucosal Irritancy
Polymericmaterials servingasvehicles fordrugdeliveryvia
mucosal routes of administration should satisfy a number14, 14, 225–234
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Figure 3. Turbidity of PAA–MC solution mixtures a) 30:70, b)
50:50, and c) 70:30wt% at different polymer concentrations
and pH.
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230of criteria and one of the most important requirements
is their biocompatibility. Biocompatibility of polymeric
excipients is of paramount importance for ocular drug
delivery as the human eye is a very sensitive organ that canMacromol. Biosci. 20
 2013 The Authors. Published by WILEY-VCHbe easily irritated. Traditionally testing for ocular irritancy
has been done using so-called Draize test, where an
excipient is administered into the conjuctival sac of one
eye of an albino rabbit and the other eye serves as a
control.[24]However, prior to invivo experiments on rabbits
it would be useful to have a preliminary screening for
the ocular irritancy using some alternative testing
methodologies.
Alternatives to the Draize test are continuously being
sought and one of themethodologies has been proposed by
Adriaens and Remon.[25–29] Their test involves the use of
invertebrate organisms such as terrestrial slugs. Slugs have
a very sensitive mucosal surface, which releases mucus to
aid locomotion and in response to irritation. Adriaens and
Remon have demonstrated that amount of the mucus
released is directly related to the toxicity of chemicals and
can beused as a quantitativemeasure formucosal irritancy
ofvariousexcipients. SMITwasalsovalidated inrabbitsand
compared against libraries of reference substances.
Previously we reported the use of SMIT for assessing
mucosal irritancy of random copolymers based on 2-
hydroxyethylmethacrylate and 2-hydroxyethylacrylate[18]
and in the present work we have used the same
methodology for evaluating the biocompatibility of PAA–
MC films. Two species of slugs (Limax flavus and Arion
lusitanicus) were used in our experiments to provide a
comparative assessment. Figure 5 presents data on mucus
production by slugs exposed to 1h contact with films
containing various quantities of MC. 2% solution of
benzalkonium chloride was used as a positive control as
it causes a severe irritation to slugs with the production of
yellow mucus reaching 33 12% and 40 13% for Limax
flavus and Arion lusitanicus, respectively (see Figure 1S in
Supporting Information for the images of slugs exposed
to various materials). Slugs exposed to filter paper
surfaces soaked with phosphate buffer saline (used as a
negative control) did show low levels ofmucus production:
3 2% and 4 2% for Limax flavus and Arion lusitanicus,
respectively.
Films consisting of pure PAA displayed significantly
higher irritancy (p< 0.001) compared to negative controls,
with the levels of mucus production reaching 15 7% and
8 2% for Limax flavus and Arion lusitanicus, respectively.
This result is consistent with the literature data[8] and our
previous observations,[18] confirming that PAA and its
derivatives have some tendency to cause irritation to
mucosal tissues. However, themucosal irritation caused by
exposure of slugs to 100% PAA films is still significantly
lower than the effect of positive controls used (p< 0.05
and p< 0.001 for Limax flavus and Arion lusitanicus,
respectively).
Films containing increasing quantities of MC showed a
reduction in their irritation potential as no significant
differences were observed between PAA–MC blend films14, 14, 225–234
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Figure 4. Morphology of PAA – MC complexes and blends (50:50wt%) at different pH: a) 2.5, b) 3.0, c) 3.4, d) 4.0, e) 4.4, and f) 8.3.
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used (p> 0.1). In the case of Limax flavus, the mucus
production by slugs in response to contact with PAA–MC
films was significantly higher than the negative control
(p< 0.05), but still lower compared to 100% PAA (p< 0.05).Macromol. Biosci. 20
 2013 The Authors. Published by WILEY-Vwww.MaterialsViews.comLenoir et al.,[29] reported that mucus production (MP) of
3% observed in Arion lusitanicus species should correspond
to the compounds that do not cause any ocular discomfort
and MP> 15% should be associated with the chemicals
causing severe stinging, itching and burning sensation.14, 14, 225–234
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Figure 5. Biocompatibility of PAA–MC films assessed using slug
mucosa irritation test: mucus production by a) Limax flavus and b)
Arion lusitanicus in response to 60min exposure to PAA–MC films
as well as positive and negative controls
www.mbs-journal.de
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232Despite the difference in the experimental protocols used
by Lenoir et al.[29] and in our study, these data are broadly
comparable with our results. It allows us to conclude that
mucosal irritancy of PAA films can be reduced significantly
upon its blending with MC.3.4. In Vitro Release of Riboflavin from PAA–MC
Films
Riboflavin is a drug that is widely used for treatment of
keratoconus, a degenerative condition of the cornea in
the eye, leading to serious vision distortion.[30] Wollensak
et al.[31] established a novel treatment method for
keratoconus with the use of riboflavin as a photosensitive
compound for UV-mediated collagen cross-linking in the
diseased cornea. This procedure involves physical removal
of the epithelium to allow riboflavin to saturate the
corneal stroma. Once cornea of a patient is saturated withMacromol. Biosci. 20
 2013 The Authors. Published by WILEY-VCHriboflavin the eye is irradiated with UV-light to cause
cross-linking of stromal collagen. Although the application
of this method leads to successful restoration of the
shape and mechanical integrity of the cornea, physical
removal of corneal epithelium is a highly unpleasant
procedure and a patient would be uncomfortable during
recovery. Therefore, formulation approaches that could
potentially lead to development of efficient riboflavin
delivery to the corneawithout recourse to physical removal
of corneal epithelium are of significant interest.[32,33]
Two forms of this drug could potentially be used for
corneal cross-linking procedure: riboflavin-5-phosphate
and riboflavin base. 0.1% riboflavin 5-phosphate is current-
ly used in clinical applications in aqueous mixtures with
dextran. This compound is hydrophilic and has a better
affinity to the corneal stroma compared to its hydrophobic
counterpart.[33] However, the transepithelial permeability
of riboflavin base is expected to be greater as the corneal
epithelium is a lipophilic tissue.
In the present study, we have used more hydrophobic
riboflavinderivative to formulate ocular PAA–MCfilms (see
Figure 2S in Supporting Information for exemplary image
of these films). In vitro experiments were performed to
evaluate the films dissolution and riboflavin release into
simulated tear fluid (Figure 6). The quickest release of
riboflavin was observed from pure PAA-based films reach-
ing 94 9% drug liberation in 40min and resulting in
a complete dissolution of polymeric material. This is
expected as PAA is a highly hydrophilic polymer that
typically undergoes a relatively quick dissolution.[23]
Films based on pure MC and PAA–MC (30:70wt%) gave
the slowest dissolution with approximately 69 6% of
riboflavin released in 40min (no significant difference in
the release profiles was observed between pure MC and
PAA–MC (30:70wt%), p> 0.5). MC as a semi-rigid polymer
takes longer to dissolve, which substantially slows down
the release of the riboflavin. Films containing 30wt% MC
showed a significantly slower release of riboflavin com-
pared to pure PAA (p< 0.05), but no significant difference
with pure MC (p> 0.5). Films with 50wt% of MC gave a
significantly faster release compared to pure MC (p< 0.05),
but insignificant difference from PAA (p> 0.05).3.5. In Vivo Retention of the Films
In vivo experiments on ocular administration of riboflavin-
loaded PAA–MC films were performed on rabbits. In each
experiment, the films were quickly soaked in 0.9% NaCl
solution (10 s) to make them more flexible and adhesive,
and then were administered directly on rabbits’ cornea. A
distinct yellow colour of riboflavin was very helpful to
monitor the behavior of the films visually and using digital
photography (Figure 4S in Supporting Information for
exemplary image). During these experiments it was14, 14, 225–234
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Figure 6. In Vitro release of riboflavin from PAAMC films. Error
bars are not shown on the figure to avoid overcrowding.
Individual release curves with error bars can be found in
Supporting Information (Figure 3S).
Hydrogen-Bonded Complexes and Blends of Poly(acrylic acid) . . .
www.mbs-journal.deconcluded that the three main parameters are important
for making polymeric films efficient for ocular delivery of
riboflavin: 1) film flexibility that helps easier fitting to
provide intimate contactwith the cornea; 2) abalancedfilm
mucoadhesivity (completely non-adhesive films are diffi-
cult to fit as they do not attach to the cornea, whereas
excessively adhesive materials cause problems because of
their sticking to eyelids); 3) film dissolution time in tear
fluid as it affects the drug retention characteristics.
Table 1 summarizes the results of in vivo experiments
with different PAA–MC formulations. It should be noted
that because of the experimental techniqueused thesedata
provide only a rough estimate of the retention time for the
films on the corneal surface. Films composed of pure MC
were found to retain for up to 50minon the corneal surface.
The extended residence of MC-based films on the cornea is
believed to be related to lower chain flexibility and lower
hydrophilicity of MC compared to PAA, which provides the
cellulose ether better retention ability due to its longerTable 1. In vivo experiments on retention of PAA–MC films on
rabbits’ cornea.
Polymeric film:
PAA/MC [wt%]
Retention timeon
the cornea[min]
0/100 50
30/70 30
50/50 60
70/30 30
100/0 10
Macromol. Biosci. 20
 2013 The Authors. Published by WILEY-Vwww.MaterialsViews.comdissolution. Indeed, the films remained on the corneal
surface in the formofhydrated gel that gradually dissolved.
Additionally, the excellent biocompatibility of MC
ensured that there was no excessive tear production
observed during these experiments. However, the disad-
vantage of pure MC-films was related to the difficulties of
initial administration/attachment to the cornea related
to their poor mucoadhesive characteristics. Pure PAA-
based films, on the contrary, demonstrated a very poor
retention on the cornea (10min), which is related to their
high hydrophilicity and some irritation properties that
caused excessive tear production and more efficient film
removal from the cornea. Although excellent mucoadhe-
sive properties of PAA were noticed during these experi-
ments upon initial administration, they were found to be
detrimental for this application because of unwanted
sticking of the films to eyelid mucosa. Films consisting of
a combination of PAA and MC exhibited a retention
capability, which ranged within 30–60min. These films
were also found to have good balance of mucoadhesive
characteristics to ensure easier fitting/attachment to
corneal surface and relatively good retention.
All rabbit eyes were visually examined following the
use of these films and no signs for adverse irritation
were observed (no redness of conjunctiva; details of iris
were clearly visible). Higher tear production was observed
in the case of pure PAA, indicating some minor irritation
potential, which is consistent with the evaluation of this
material biocompatibility using SMIT.
The application of riboflavin-loaded ocular films can be
considered as a new strategy to deliver this drug to the
cornea for subsequent UV-mediated corneal cross-linking.
Compared to conventional riboflavin eye drops the use of
ocular films will provide improved pre-corneal retention.
Once the film is completely dissolved and riboflavin
saturated the cornea theUV-irradiation can be commenced
to induce cross-linking. It should be noted that the
current levels of riboflavin delivered to the eye using our
films are relatively low (maximum content of the drug in
the film was around 40mg) and not fully comparable with
0.1% solution of riboflavin 5-phosphate typically used in
clinical settings. Further experiments will be required to
formulate riboflavin films with higher drug content.4. Conclusion
This study demonstrates the effect of pH on hydrogen
bonding between poly(acrylic acid) and methylcellulose
in aqueous solutions. Mixing dilute aqueous solutions of
these polymers at pHs< 3.4 results in formation of IPC as
nanoparticles. These nanoparticles may undergo further
aggregation resulting in the formation of larger species.
Polymeric films prepared by casting solutions mixed at14, 14, 225–234
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234these pHs have poor transparency and are not fully
uniform. When poly(acrylic acid) and methylcellulose are
mixed and cast at 3.4<pH< 4.5 the films are uniform,
transparent, and show a complete miscibility between the
polymers. Hydrogen bonding between the polymers is still
present under these pH conditions, but it is not sufficient to
form IPC.Whenhydrogenbonding is completelyprevented,
for example, at pH 8.3, the films are inhomogeneous again
because of immiscibility between the polymers.
Films loaded with riboflavin were prepared by casting
polymer solutions mixed with the drug at pH 4.5. The
release of riboflavin from these films was studied in vitro
into artificial tear fluid. It was established that films
enriched with methylcellulose show a significantly slower
release of riboflavin compared to samples containing high
quantities of poly(acrylic acid).
In vivo retention of riboflavin-loaded films was studied
in rabbits. Pure methylcellulose films exhibited retention
up to 50min but were not sufficiently adhesive for their
successful application. Pure poly(acrylic acid) films showed
excessive adhesiveness and poor retention (up to 10min).
Films composed of both poly(acrylic acid) and methylcellu-
lose exhibited relatively good adhesiveness and retention
for 30–60min. In principle this is a good improvement
compared to simple riboflavin eye drops; however, accord-
ing toour recentdiffusion studies,[31] riboflavin takes longer
time to penetrate into the cornea. A lag time of at least
90min was observed for riboflavin penetrating freshly
excised bovine cornea. Further optimization of the proper-
ties of these films will still be required to improve their
characteristics and to achieve at least 90min retention. This
improvementcanpotentiallybeachievedviaapartial cross-
linking of these materials. Additionally more complex film
formulations could be designed to incorporate permeability
enhancers or nanoemulsions, whose function will be to
facilitate transepithelial permeation of riboflavin.[32,33]Acknowledgements: This work was partially supported by the
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